
Bruck Kifle
Examiner (ID: 2332)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 1624, 1611, 1622 |
| Total Applications | 3434 |
| Issued Applications | 2601 |
| Pending Applications | 222 |
| Abandoned Applications | 651 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7111810
[patent_doc_number] => 20050209266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/135308
[patent_app_country] => US
[patent_app_date] => 2005-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23854
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209266.pdf
[firstpage_image] =>[orig_patent_app_number] => 11135308
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/135308 | Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use | May 23, 2005 | Issued |
Array
(
[id] => 7250771
[patent_doc_number] => 20050272754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Polymorphic forms of rifaximin, processes for their production and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/135651
[patent_app_country] => US
[patent_app_date] => 2005-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14855
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272754.pdf
[firstpage_image] =>[orig_patent_app_number] => 11135651
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/135651 | Polymorphic forms of rifaximin, processes for their production and uses thereof | May 23, 2005 | Abandoned |
Array
(
[id] => 823748
[patent_doc_number] => 07405220
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-29
[patent_title] => 'Pyrazolopyrimidines'
[patent_app_type] => utility
[patent_app_number] => 11/136023
[patent_app_country] => US
[patent_app_date] => 2005-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13232
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/405/07405220.pdf
[firstpage_image] =>[orig_patent_app_number] => 11136023
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/136023 | Pyrazolopyrimidines | May 23, 2005 | Issued |
Array
(
[id] => 4977980
[patent_doc_number] => 20070219213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Use of Adrenergic N-Phenylpiperazine Antagonists, Pahrmaceutical Compositions Containning Them, and Methods of Preparing Them'
[patent_app_type] => utility
[patent_app_number] => 11/569025
[patent_app_country] => US
[patent_app_date] => 2005-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17917
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20070219213.pdf
[firstpage_image] =>[orig_patent_app_number] => 11569025
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/569025 | Use of Adrenergic N-Phenylpiperazine Antagonists, Pahrmaceutical Compositions Containning Them, and Methods of Preparing Them | May 19, 2005 | Abandoned |
Array
(
[id] => 728706
[patent_doc_number] => 07041663
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-09
[patent_title] => '2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents'
[patent_app_type] => utility
[patent_app_number] => 11/133113
[patent_app_country] => US
[patent_app_date] => 2005-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36251
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/041/07041663.pdf
[firstpage_image] =>[orig_patent_app_number] => 11133113
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/133113 | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | May 18, 2005 | Issued |
Array
(
[id] => 5771649
[patent_doc_number] => 20050267100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Tetraazabenzo[e]azulene derivatives and analogs thereof'
[patent_app_type] => utility
[patent_app_number] => 11/134790
[patent_app_country] => US
[patent_app_date] => 2005-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39224
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20050267100.pdf
[firstpage_image] =>[orig_patent_app_number] => 11134790
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/134790 | Tetraazabenzo[e]azulene derivatives and analogs thereof | May 18, 2005 | Issued |
Array
(
[id] => 5771595
[patent_doc_number] => 20050267046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Geldanamycin compounds and method of use'
[patent_app_type] => utility
[patent_app_number] => 11/133880
[patent_app_country] => US
[patent_app_date] => 2005-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7644
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20050267046.pdf
[firstpage_image] =>[orig_patent_app_number] => 11133880
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/133880 | Geldanamycin compounds and method of use | May 16, 2005 | Issued |
Array
(
[id] => 876411
[patent_doc_number] => 07358241
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-15
[patent_title] => 'Compositions and methods comprising farnesyl dibenzodiazepinones for treating neoplastic cells and conditions'
[patent_app_type] => utility
[patent_app_number] => 11/130295
[patent_app_country] => US
[patent_app_date] => 2005-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15986
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/358/07358241.pdf
[firstpage_image] =>[orig_patent_app_number] => 11130295
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/130295 | Compositions and methods comprising farnesyl dibenzodiazepinones for treating neoplastic cells and conditions | May 15, 2005 | Issued |
Array
(
[id] => 5609145
[patent_doc_number] => 20060270661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Pyrrolobenzodiazepines'
[patent_app_type] => utility
[patent_app_number] => 11/129207
[patent_app_country] => US
[patent_app_date] => 2005-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4701
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20060270661.pdf
[firstpage_image] =>[orig_patent_app_number] => 11129207
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/129207 | Pyrrolobenzodiazepines | May 12, 2005 | Issued |
Array
(
[id] => 7020124
[patent_doc_number] => 20050222143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Helix mimetics and composition and methods related thereto'
[patent_app_type] => utility
[patent_app_number] => 11/121337
[patent_app_country] => US
[patent_app_date] => 2005-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14421
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222143.pdf
[firstpage_image] =>[orig_patent_app_number] => 11121337
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/121337 | Helix mimetics and composition and methods related thereto | May 2, 2005 | Issued |
Array
(
[id] => 5070235
[patent_doc_number] => 20070191337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Annellated carbamyl-aza-heterocyclic compounds, a focused library, pharmaceutical compositions, and methods of preparing the same'
[patent_app_type] => utility
[patent_app_number] => 11/547874
[patent_app_country] => US
[patent_app_date] => 2005-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5466
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191337.pdf
[firstpage_image] =>[orig_patent_app_number] => 11547874
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/547874 | Annellated carbamyl-aza-heterocyclic compounds, a focused library, pharmaceutical compositions, and methods of preparing the same | Apr 28, 2005 | Abandoned |
Array
(
[id] => 7233431
[patent_doc_number] => 20050256096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'C-25 carbamate rifamycin derivatives with activity against drug-resistant microbes'
[patent_app_type] => utility
[patent_app_number] => 11/114384
[patent_app_country] => US
[patent_app_date] => 2005-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 27212
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20050256096.pdf
[firstpage_image] =>[orig_patent_app_number] => 11114384
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/114384 | C-25 carbamate rifamycin derivatives with activity against drug-resistant microbes | Apr 25, 2005 | Issued |
Array
(
[id] => 6912962
[patent_doc_number] => 20050176720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Pharmaceutical composition for the treatment of CNS and other disorders'
[patent_app_type] => utility
[patent_app_number] => 11/106778
[patent_app_country] => US
[patent_app_date] => 2005-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19360
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176720.pdf
[firstpage_image] =>[orig_patent_app_number] => 11106778
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/106778 | Pharmaceutical composition for the treatment of CNS and other disorders | Apr 14, 2005 | Abandoned |
Array
(
[id] => 6931822
[patent_doc_number] => 20050282857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 11/107195
[patent_app_country] => US
[patent_app_date] => 2005-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10224
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282857.pdf
[firstpage_image] =>[orig_patent_app_number] => 11107195
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/107195 | Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions | Apr 14, 2005 | Abandoned |
Array
(
[id] => 5794050
[patent_doc_number] => 20060014731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Analogs of benzoquinone-containing ansamycins and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/108165
[patent_app_country] => US
[patent_app_date] => 2005-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 88
[patent_figures_cnt] => 88
[patent_no_of_words] => 38686
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014731.pdf
[firstpage_image] =>[orig_patent_app_number] => 11108165
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/108165 | Analogs of benzoquinone-containing ansamycins and methods of use thereof | Apr 13, 2005 | Issued |
Array
(
[id] => 478898
[patent_doc_number] => 07223762
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-29
[patent_title] => 'Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4'
[patent_app_type] => utility
[patent_app_number] => 11/107447
[patent_app_country] => US
[patent_app_date] => 2005-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27881
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/223/07223762.pdf
[firstpage_image] =>[orig_patent_app_number] => 11107447
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/107447 | Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 | Apr 13, 2005 | Issued |
Array
(
[id] => 872367
[patent_doc_number] => 07361647
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-22
[patent_title] => 'Analogs of benzoquinone-containing ansamycins and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/107404
[patent_app_country] => US
[patent_app_date] => 2005-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 88
[patent_figures_cnt] => 99
[patent_no_of_words] => 38745
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/361/07361647.pdf
[firstpage_image] =>[orig_patent_app_number] => 11107404
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/107404 | Analogs of benzoquinone-containing ansamycins and methods of use thereof | Apr 13, 2005 | Issued |
Array
(
[id] => 267180
[patent_doc_number] => 07566706
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-28
[patent_title] => 'Analogs of benzoquinone-containing ansamycins and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/105203
[patent_app_country] => US
[patent_app_date] => 2005-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 87
[patent_figures_cnt] => 99
[patent_no_of_words] => 38697
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/566/07566706.pdf
[firstpage_image] =>[orig_patent_app_number] => 11105203
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/105203 | Analogs of benzoquinone-containing ansamycins and methods of use thereof | Apr 12, 2005 | Issued |
Array
(
[id] => 6967189
[patent_doc_number] => 20050234086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Proline CCI-779, production of and uses therefor, and two-step enzymatic synthesis of proline CCI-779 and CCI-779'
[patent_app_type] => utility
[patent_app_number] => 11/103779
[patent_app_country] => US
[patent_app_date] => 2005-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9129
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20050234086.pdf
[firstpage_image] =>[orig_patent_app_number] => 11103779
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/103779 | Proline CCI-779, production of and uses therefor, and two-step enzymatic synthesis of proline CCI-779 and CCI-779 | Apr 11, 2005 | Issued |
Array
(
[id] => 6967337
[patent_doc_number] => 20050234234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Regiospecific synthesis of rapamycin 42-ester derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/103799
[patent_app_country] => US
[patent_app_date] => 2005-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3401
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20050234234.pdf
[firstpage_image] =>[orig_patent_app_number] => 11103799
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/103799 | Regiospecific synthesis of rapamycin 42-ester derivatives | Apr 11, 2005 | Issued |